Welcome to our research group site!

Our group (head: Prof. Dr. med. Norbert Suttorp) is part of the Department of Infectious Diseases, Respiratory-, and Critical Care Medicine of the Charité – Universitätsmedizin Berlin.

Every year, pneumonia leads to hospital admissions as much as myocardial infarction or stroke. In this sense, pneumonia is a widespread disease.

The spectrum of the work group ranges from molecular medicine to system medicine as well as from the molecule up to the patient.

The SFB-TR84 (DFG) is oriented to basic science and examines  innate immunity of the lung with regard to pathogen attack and host defense in the lung inflammation.

In the CAPNETZ collaborative project (BMBF funding), more than 11,000 patients have been recruited and thoroughly characterized. Many aspects of care research on the topic of “ambulatory acquired pneumonia” are being considered.

The main goal of the BMBF-funded project PROGRESS is to identify transcription and proteome-based signatures as well as biomarkers and genetic polymorphisms associated with outpatient or hospital-acquired severe pneumonia. The focus of the project is the analysis of determinants of transition from complicated outpatient pneumonia to severe respiratory pneumonia to severe pneumonia plus sepsis.

CAPSys (BMBF funding) stands for systemic medicine of ambulatory acquired pneumonia and is an interdisciplinary research group, which investigates causes and developmental forms of severe lung inflammation. The aim is to find novel signatures from clinical and molecular data for an imminent barrier disorder in the lung of pneumonia patients and to provide a better understanding of the pathogenetic mechanisms of this process.